Warning issued after the death of an immuno-compromised patient following Zostavax administration The Therapeutic Goods Administration has reiterated previous warnings about administering the Zostavax shingles vaccine to patients with immune systems deficiencies. The warning comes after the death of a patient who was also on low doses of immunosuppressive medicine. The patient, who at the
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.